Innovation

Bachem Innovates its Manufacturing Capabilities

Interest in oligonucleotide therapeutics has grown, as has the market demand, since their emergence as a new drug modality two decades ago.

Expert Statement: Jean-Baptiste Guillermin, Axplora

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Stephen D Drake, Kaneka Americas Holdings

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Christophe Girard, Siegfried

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Baburaj Krishnan, Aurigene Pharmaceutical Services

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Mark Muldowney, Sterling Pharma Solutions

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Srividya Ramakrishnan, Dr. Reddy’s Laboratories

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Ulrich Mayerhoeffer, Arxada

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Shawn Walker, Veranova

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

Expert Statement: Kai Rossen, Euroapi

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.

New Covid Shots Score Points against Omicron

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.

Empowering Frontline Workers with AI

Interview with Russ Fadel, Augmentir

AI Makes Drug Discovery Faster

Interview with Joachim Haupt and Florian Kaiser, PharmAI

Nanoparticle Engineering

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.

Quantum Computational Toxicology

Interview with Pedro Lopes, FastCompChem

Blockchain in Chemical Value Chains

Interview with Jens Schmidt, ReCarbonX

Providing Circular Side Stream Solutions

Interview with Steven De Laet, InOpSys

Enabling the Best Possible Drug

Interview with Oliver Reimann and Andreas Regnery, Belyntic

Transforming the Scale-Up of Biobased Molecules

Interview with Jere Koskinen and Ali Harlin, Mega Cellulose.

Redesigning Tomorrow’s Plastics Today

B4Plastics is a Belgium-based biotechnology start-up and a polymer architecture company looking to catalyze the introduction of novel biomaterials and growing them from niche to bulk applications.

Artificial Intelligence for New Drug Design

Digital tools are a key to shortening the development of active pharmaceutical ingredients and thus market-ready drugs and therapies.

Rethinking the Base Material Side

Plafco Fibertech, founded in 2017, was created as a spin-off from an EU-research project coordinated by Jukka Valkama, a professor at the Cooperative State University of Baden Wurttemberg in Karlsruhe, Germany.

Paving the Way for Sustainable Infection Control

LipoCoat is a biotech company specialized in ‘bio-inspired’ coatings that improve the safety, comfort, and performance of medical devices with a focus on health and nutrition.

Vaccine Filling at the Highest Level

Recent studies show that contract manufacturers for the pharmaceutical industry, so-called CDMOs (contract development and manufacturing organizations), have so far been little involved in the production of vaccines. This is changing with the outbreak of the Covid-19 pandemic.

New Ammonia Synthesis Technology

Tsubame BHB was established in April of 2017 based on a new catalyst technology developed by Prof. em. Hideo Hosono at the ­Tokyo Institute of Technology (Tokyo Tech), which allows an ammonia process at lower temperature and pressure.

Excited About Coatings

Affix Labs over the past 5 years has specialized in binding technologies and commercialized first products in 2019.

A New Standard for Process Simulation — and Beyond

Hafnium Labs is tackling one of the toughest challenges in chemical R&D: Obtaining reliable physical property data — fast.

Accelerated Drug Discovery

In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.

Glucose Control of Bioprocesses

Online Monitoring and Control of Bioreactors by Mid-Infrared Spectroscopy

Revolutionizing Surface Functionalization

Single-step, Ambient, Dry Grafting of Organic Compounds and Biomolecules onto any Substrate.

Reshaping Adhesion - and the Industry

Hybrid assemblies, joints of dissimilar materials, are everywhere - in our smartphones, cars, TVs, dishwashers, in planes and so on. However, in modern products we increasingly rely on plastics, which are intrinsically hard to bond to other types of material — and by using industrial glue for the bonding the parts cannot be recy­cled easily. Solving this monumental challenge inspired the foun­dation of the Danish start-up company RadiSurf five years ago.

Creating the AI-Powered Future of Chemistry

Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.

Webinar: UV Disinfection of Surfaces and Air

Smart Tools for Chemical Research

Iris.ai was founded at Singularity University at NASA Ames Research Park in 2015. Challenged to come up with an idea that would positively impact the lives of 1 billion people, the team was formed and problem areas were explored.

Expert Webinar: Efficient and Innovative Labs in the 21st Century